NCT02111499 Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test Status COMPLETED Phase PHASE1/PHASE2
NCT02107482 Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis Status COMPLETED Phase NA
NCT02103361 Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project Status RECRUITING Phase N/A
NCT02101216 Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02097173 Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen Status COMPLETED Phase PHASE1
NCT02075632 Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream Status COMPLETED Phase PHASE2
NCT02054481 BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab Status COMPLETED Phase PHASE2
NCT02047851 Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis Status TERMINATED Phase NA
NCT01999868 Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris Status COMPLETED Phase PHASE2
NCT01993433 A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01991197 Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial. Status COMPLETED Phase PHASE2
NCT01988506 Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases Status COMPLETED Phase PHASE2
NCT01988103 Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis Status COMPLETED Phase PHASE2
NCT01987609 Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques Status COMPLETED Phase PHASE2
NCT01984775 A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01971346 The Immunological Basis for Treatment Resistance to Anti-TNF Treatments Status COMPLETED Phase PHASE4
NCT01970488 Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01967069 A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis Status COMPLETED Phase PHASE3